{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:47:20Z","timestamp":1782863240880,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province Project","award":["KYCX24_3599"],"award-info":[{"award-number":["KYCX24_3599"]}]},{"name":"Jiangsu Provincial Research Hospital Project","award":["YJXYY202204-YSB05"],"award-info":[{"award-number":["YJXYY202204-YSB05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12256-1","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:49:24Z","timestamp":1782859764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CC chemokines in epithelial ovarian cancer: orchestrating the metastatic microenvironment and therapy resistance"],"prefix":"10.1007","volume":"53","author":[{"given":"Bing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6561-8598","authenticated-orcid":false,"given":"Yuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"12256_CR1","doi-asserted-by":"crossref","unstructured":"Li R, Zhao A, Liu M, Lu L, Li B, Zeng H (2026) Global epidemiology of ovarian cancer: patterns, trends, and risk factors. Cancer Biol Med 24:1\u201316. Online ahead of print","DOI":"10.20892\/j.issn.2095-3941.2025.0619"},{"key":"12256_CR2","doi-asserted-by":"crossref","unstructured":"Papageorgiou D, Liouta G, Pliakou E, Zachariou E, Sapantzoglou I, Prokopakis I et al (2025) Management of advanced ovarian cancer: current clinical practice and future perspectives. Biomed 13(7):1525","DOI":"10.3390\/biomedicines13071525"},{"key":"12256_CR3","doi-asserted-by":"crossref","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP et al (2023) Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond) 43(5):525\u2013561","DOI":"10.1002\/cac2.12416"},{"key":"12256_CR4","doi-asserted-by":"crossref","unstructured":"Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I (2020) CC Chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int J Mol Sci 21(20) :7619","DOI":"10.3390\/ijms21207619"},{"key":"12256_CR5","doi-asserted-by":"crossref","unstructured":"Lischetti U, Liang CY, Carrara M, Coelho R, Hanns A, Lombardo F et al (2025) Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming. Nat Commun 17(1):849","DOI":"10.1038\/s41467-025-67557-z"},{"key":"12256_CR6","doi-asserted-by":"crossref","unstructured":"Elhanani O, Ben-Uri R, Keren L (2023) Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell 41(3):404\u2013420","DOI":"10.1016\/j.ccell.2023.01.010"},{"key":"12256_CR7","doi-asserted-by":"crossref","unstructured":"Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121\u2013127","DOI":"10.1016\/S1074-7613(00)80165-X"},{"key":"12256_CR8","doi-asserted-by":"crossref","unstructured":"Liu W, Wang L, Zhang J, Cheng K, Zheng W, Ma Z (2023) CC chemokine 2 promotes ovarian cancer progression through the MEK\/ERK\/MAP3K19 signaling Pathway. Int J Mol Sci 24(13):10652","DOI":"10.3390\/ijms241310652"},{"key":"12256_CR9","doi-asserted-by":"crossref","unstructured":"Hughes CE, Nibbs RJB (2018) A guide to chemokines and their receptors. Febs j 285(16):2944\u20132971","DOI":"10.1111\/febs.14466"},{"key":"12256_CR10","doi-asserted-by":"crossref","unstructured":"\u015aliwa A, Szczerba A, Pi\u0119ta PP, Bia\u0142as P, Lorek J, Nowak-Markwitz E et al (2024) A recipe for successful metastasis: transition and migratory modes of ovarian Cancer cells. Cancers (Basel) 16(4):783","DOI":"10.3390\/cancers16040783"},{"key":"12256_CR11","doi-asserted-by":"crossref","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A (2023) The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol 20(7):714\u2013738","DOI":"10.1038\/s41423-023-01013-0"},{"key":"12256_CR12","doi-asserted-by":"crossref","unstructured":"Jin Y, Wang Y, Yang R (2025) Chemokine ligand 2: beyond chemotaxis-a multifaceted role in tumor progression. Front Immunol 16:1685474","DOI":"10.3389\/fimmu.2025.1685474"},{"key":"12256_CR13","doi-asserted-by":"crossref","unstructured":"Yang YI, Wang YY, Ahn JH, Kim BH, Choi JH (2022) CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment. Biomed Pharmacother 153:113474","DOI":"10.1016\/j.biopha.2022.113474"},{"key":"12256_CR14","doi-asserted-by":"crossref","unstructured":"Li X, Fang T, Xu S, Jin P, Zhou D, Wang Z et al (2021) PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. NPJ Precis Oncol 5(1):49","DOI":"10.1038\/s41698-021-00189-w"},{"key":"12256_CR15","doi-asserted-by":"crossref","unstructured":"Kim S, Han Y, Kim SI, Lee J, Jo H, Wang W et al (2021) Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer. Mol Carcinog 60(5):297\u2013312","DOI":"10.1002\/mc.23289"},{"key":"12256_CR16","doi-asserted-by":"crossref","unstructured":"Zeng Z, Lan T, Wei Y, Wei X (2022) CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis 9(1):12\u201327","DOI":"10.1016\/j.gendis.2021.08.004"},{"key":"12256_CR17","doi-asserted-by":"crossref","unstructured":"Korbecki J, Olbromski M, Dzi\u0119giel P (2020) CCL18 in the progression of cancer. Int J Mol Sci. ;21(21) :7955.","DOI":"10.3390\/ijms21217955"},{"key":"12256_CR18","doi-asserted-by":"crossref","unstructured":"Long L, Hu Y, Long T, Lu X, Tuo Y, Li Y et al (2021) Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. J Immunother Cancer. ;9(12) :e003973.","DOI":"10.1136\/jitc-2021-003973"},{"key":"12256_CR19","doi-asserted-by":"crossref","unstructured":"Chen J, Yao Y, Gong C, Yu F, Su S, Chen J et al (2011) CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19(4):541\u2013555","DOI":"10.1016\/j.ccr.2011.02.006"},{"key":"12256_CR20","doi-asserted-by":"crossref","unstructured":"Liu S, Tao Z, Lou J, Li R, Fu X, Xu J et al (2023) CD4(+)CCR8(+) Tregs in ovarian cancer: a potential effector Tregs for immune regulation. J Transl Med 21(1):803","DOI":"10.1186\/s12967-023-04686-3"},{"key":"12256_CR21","doi-asserted-by":"crossref","unstructured":"Kwantwi LB, Boafo JD, Egleh BE, Li M (2025) CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches. Clin Transl Oncol 27(8):3285\u20133292","DOI":"10.1007\/s12094-025-03874-5"},{"key":"12256_CR22","doi-asserted-by":"crossref","unstructured":"Ignacio RM, Kabir SM, Lee ES, Adunyah SE, Son DS (2016) NF-\u03baB-mediated CCL20 reigns dominantly in CXCR2-driven ovarian cancer progression. PLoS ONE 11(10):e0164189","DOI":"10.1371\/journal.pone.0164189"},{"key":"12256_CR23","doi-asserted-by":"crossref","unstructured":"Liu Q, Song M, Wang Y, Zhang P, Zhang H (2025) CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting. Biochim Biophys Acta Rev Cancer 1880(3):189341","DOI":"10.1016\/j.bbcan.2025.189341"},{"key":"12256_CR24","doi-asserted-by":"crossref","unstructured":"Wertel I, Sur\u00f3wka J, Polak G, Barczy\u0144ski B, Bednarek W, Jakubowicz-Gil J et al (2015) Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. Tumour Biol 36(6):4811\u20134817","DOI":"10.1007\/s13277-015-3133-8"},{"key":"12256_CR25","doi-asserted-by":"crossref","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W (2023) Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):70","DOI":"10.1038\/s41392-023-01332-8"},{"key":"12256_CR26","doi-asserted-by":"crossref","unstructured":"Mei S, Chen X, Wang K, Chen Y (2023) Tumor microenvironment in ovarian cancer peritoneal metastasis. Cancer Cell Int 23(1):11","DOI":"10.1186\/s12935-023-02854-5"},{"key":"12256_CR27","doi-asserted-by":"crossref","unstructured":"Lv Y, Chen C, Han M, Tian C, Song F, Feng S et al (2025) CXCL2: a key player in the tumor microenvironment and inflammatory diseases. Cancer Cell Int 25(1):133","DOI":"10.1186\/s12935-025-03765-3"},{"key":"12256_CR28","doi-asserted-by":"crossref","unstructured":"Liu Y, Xiao H, Zeng H, Xiang Y (2024) Beyond tumor\u2013associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review). Int J Oncol. ;65(6) :117.","DOI":"10.3892\/ijo.2024.5705"},{"key":"12256_CR29","doi-asserted-by":"crossref","unstructured":"Zhang JJ, Liu W, Xing GZ, Xiang L, Zheng WM, Ma ZL (2022) Role of CC-chemokine ligand 2 in gynecological cancer. Cancer Cell Int 22(1):361","DOI":"10.1186\/s12935-022-02763-z"},{"key":"12256_CR30","doi-asserted-by":"crossref","unstructured":"Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY et al (2013) An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 4(11):e915","DOI":"10.1038\/cddis.2013.442"},{"key":"12256_CR31","doi-asserted-by":"crossref","unstructured":"Truxova I, Cibula D, Spisek R, Fucikova J (2023) Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma. J Immunother Cancer. ;11(2) :e005968.","DOI":"10.1136\/jitc-2022-005968"},{"key":"12256_CR32","doi-asserted-by":"crossref","unstructured":"Guo Z, Huang J, Huo X, Huang C, Yu X, Sun Y et al (2024) Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin. Sci China Life Sci 67(6):1226\u20131241","DOI":"10.1007\/s11427-023-2444-5"},{"issue":"1","key":"12256_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D et al (2025) Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. Signal Transduct Target Ther 10(1):345","journal-title":"Signal Transduct Target Ther"},{"key":"12256_CR34","doi-asserted-by":"crossref","unstructured":"Li J, Huang H, Xie R, Yang R, Wang H, Wan L (2025) Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer. Front Immunol 16:1631226","DOI":"10.3389\/fimmu.2025.1631226"},{"key":"12256_CR35","doi-asserted-by":"crossref","unstructured":"Propper DJ, Balkwill FR (2022) Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 19(4):237\u2013253","DOI":"10.1038\/s41571-021-00588-9"},{"key":"12256_CR36","doi-asserted-by":"crossref","unstructured":"Ritch SJ, Telleria CM (2022) The Transcoelomic ecosystem and epithelial ovarian cancer dissemination. Front Endocrinol (Lausanne) 13:886533","DOI":"10.3389\/fendo.2022.886533"},{"key":"12256_CR37","doi-asserted-by":"crossref","unstructured":"Ray I, Michael A, Meira LB, Ellis PE (2023) The role of cytokines in epithelial-mesenchymal transition in gynaecological cancers: a systematic review. Cells 12(3):416","DOI":"10.3390\/cells12030416"},{"key":"12256_CR38","doi-asserted-by":"crossref","unstructured":"Tedja R, Alvero AB, Fox A, Cardenas C, Pitruzzello M, Chehade H et al (2023) Generation of stable epithelial-mesenchymal hybrid cancer cells with tumorigenic potential. Cancers (Basel) 15(3):684","DOI":"10.3390\/cancers15030684"},{"key":"12256_CR39","doi-asserted-by":"crossref","unstructured":"Mukherjee A, Chiang CY, Daifotis HA, Nieman KM, Fahrmann JF, Lastra RR et al (2020) Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res 80(8):1748\u20131761","DOI":"10.1158\/0008-5472.CAN-19-1999"},{"key":"12256_CR40","doi-asserted-by":"crossref","unstructured":"Qi R, Yang J, Shen S, Yu Y, Yang Q (2025) Role of the tumor microenvironment in chemotherapy resistance in ovarian cancer and targeted therapy. J Ovarian Res 19(1):14","DOI":"10.1186\/s13048-025-01927-5"},{"key":"12256_CR41","doi-asserted-by":"crossref","unstructured":"Shifon S, Tyrinova T, Veretelnikova T, Pasman N, Chernykh E (2025) Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies. Front Immunol 16:1727183","DOI":"10.3389\/fimmu.2025.1727183"},{"key":"12256_CR42","doi-asserted-by":"crossref","unstructured":"Brulport A, Bourdon M, Vaiman D, Drouet C, Pocate-Cheriet K, Bouzid K et al (2024) An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review. Reprod Biol Endocrinol 22(1):21","DOI":"10.1186\/s12958-023-01181-8"},{"key":"12256_CR43","doi-asserted-by":"crossref","unstructured":"Song Z, Wang X, Fu J, Wang P, Chen X, Zhang D (2022) Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms. Front Surg 9:1068492","DOI":"10.3389\/fsurg.2022.1068492"},{"issue":"12","key":"12256_CR44","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.trecan.2024.09.001","volume":"10","author":"BS Chap","year":"2024","unstructured":"Chap BS, Rayroux N, Grimm AJ, Ghisoni E, Dangaj Laniti D (2024) Crosstalk of T cells within the ovarian cancer microenvironment. Trends Cancer 10(12):1116\u20131130","journal-title":"Trends Cancer"},{"key":"12256_CR45","doi-asserted-by":"crossref","unstructured":"Qin R, Ren W, Ya G, Wang B, He J, Ren S et al (2023) Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin Exp Med 23(5):1359\u20131373","DOI":"10.1007\/s10238-022-00888-z"},{"key":"12256_CR46","doi-asserted-by":"crossref","unstructured":"Liu Y, Lomeli I, Kron SJ (2024) Therapy-induced cellular senescence: potentiating tumor elimination or driving cancer resistance and recurrence? Cells 13(15):128","DOI":"10.3390\/cells13151281"},{"key":"12256_CR47","doi-asserted-by":"crossref","unstructured":"Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F (2024) Cellular senescence and SASP in tumor progression and therapeutic opportunities. Mol Cancer 23(1):181","DOI":"10.1186\/s12943-024-02096-7"},{"key":"12256_CR48","doi-asserted-by":"crossref","unstructured":"Luo Y, Xia Y, Liu D, Li X, Li H, Liu J et al (2024) Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors. Cell 187(18):4905\u201325e24","DOI":"10.1016\/j.cell.2024.06.013"},{"key":"12256_CR49","doi-asserted-by":"crossref","unstructured":"Cui K, Wang K, Huang Z (2024) Ferroptosis and the tumor microenvironment. J Exp Clin Cancer Res 43(1):315","DOI":"10.1186\/s13046-024-03235-0"},{"key":"12256_CR50","doi-asserted-by":"crossref","unstructured":"Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N et al (2022) B7-H3 suppresses antitumor immunity via the CCL2-CCR2-M2 macrophage axis and contributes to ovarian cancer progression. Cancer Immunol Res 10(1):56\u201369","DOI":"10.1158\/2326-6066.CIR-21-0407"},{"key":"12256_CR51","doi-asserted-by":"crossref","unstructured":"Karin N (2021) Chemokines in the landscape of cancer immunotherapy: how they and their receptors can be used to turn cold tumors into hot ones? Cancers (Basel) 13:24","DOI":"10.3390\/cancers13246317"},{"key":"12256_CR52","doi-asserted-by":"crossref","unstructured":"Rajtak A, Ostrowska-Le\u015bko M, \u017bak K, Tarkowski R, Kotarski J, Ok\u0142a K (2022) Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. Front Immunol 13:1018256","DOI":"10.3389\/fimmu.2022.1018256"},{"issue":"1","key":"12256_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-023-01721-6","volume":"9","author":"D Ruan","year":"2023","unstructured":"Ruan D, Wen J, Fang F, Lei Y, Zhao Z, Miao Y (2023) Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential. Cell Death Discov 9(1):434","journal-title":"Cell Death Discov"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12256-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:50:27Z","timestamp":1782859827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12256-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12256"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12256-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1062"}}